Chi Y, Zhang X, Liang D, Wang Y, Cai X, Dong J
Biol Trace Elem Res. 2022; 201(5):2442-2457.
PMID: 35871203
DOI: 10.1007/s12011-022-03361-w.
Fakhfakh R, Kmiha S, Tahri S, Feki S, Zouidi F, Abida O
J Diabetes Res. 2022; 2022:2539871.
PMID: 35656360
PMC: 9152414.
DOI: 10.1155/2022/2539871.
Moin A, Nandakumar M, Diane A, Dehbi M, Butler A
Front Immunol. 2021; 11:612584.
PMID: 33584694
PMC: 7873876.
DOI: 10.3389/fimmu.2020.612584.
Rochmah N, Faizi M, Windarti S
Clin Exp Pediatr. 2020; 63(10):402-405.
PMID: 33050689
PMC: 7568951.
DOI: 10.3345/cep.2019.01221.
Zhang X, Guan T, Yang B, Gu H, Chi Z
Cell Death Dis. 2020; 11(7):544.
PMID: 32681069
PMC: 7367835.
DOI: 10.1038/s41419-020-2731-6.
Increased islet antigen-specific regulatory and effector CD4 T cells in healthy individuals with the type 1 diabetes-protective haplotype.
Wen X, Yang J, James E, Chow I, Reijonen H, Kwok W
Sci Immunol. 2020; 5(44).
PMID: 32060144
PMC: 7566980.
DOI: 10.1126/sciimmunol.aax8767.
What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?.
Williams C, Long A
Diabetologia. 2019; 62(11):1969-1976.
PMID: 31444530
PMC: 6805822.
DOI: 10.1007/s00125-019-04975-x.
Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.
Niechcial E, Rogowicz-Frontczak A, Pilacinski S, Fichna M, Skowronska B, Fichna P
Acta Diabetol. 2018; 55(3):287-294.
PMID: 29327148
PMC: 5829102.
DOI: 10.1007/s00592-017-1091-x.
Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes.
Elmaogullari S, Ucakturk S, Elbeg S, Doger E, Tayfun M, Gurbuz F
J Clin Res Pediatr Endocrinol. 2017; 10(2):108-112.
PMID: 28943512
PMC: 5985378.
DOI: 10.4274/jcrpe.5020.
Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.
Mauvais F, Diana J, van Endert P
F1000Res. 2016; 5.
PMID: 27158463
PMC: 4847563.
DOI: 10.12688/f1000research.7411.1.
Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
Skarstrand H, Krupinska E, Haataja T, Vaziri-Sani F, Lagerstedt J, Lernmark A
Clin Exp Immunol. 2014; 179(2):220-9.
PMID: 25178386
PMC: 4298399.
DOI: 10.1111/cei.12448.
The effect of diabetes-associated autoantigens on cell processes in human PBMCs and their relevance to autoimmune diabetes development.
Vcelakova J, Blatny R, Halbhuber Z, Kolar M, Neuwirth A, Petruzelkova L
J Diabetes Res. 2013; 2013:589451.
PMID: 23841104
PMC: 3694381.
DOI: 10.1155/2013/589451.
Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus F, Balti E, Vermeulen I, DeMeester S, van Dalem A, Costa O
Clin Exp Immunol. 2012; 171(1):82-90.
PMID: 23199327
PMC: 3530099.
DOI: 10.1111/j.1365-2249.2012.04675.x.
Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine.
Orban T, Kis J
Ther Adv Endocrinol Metab. 2012; 2(1):9-16.
PMID: 23148168
PMC: 3474625.
DOI: 10.1177/2042018810390546.
The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes.
Hamad A, Arcara K, Uddin S, Donner T
Front Immunol. 2012; 3:196.
PMID: 22807927
PMC: 3395106.
DOI: 10.3389/fimmu.2012.00196.
Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
Delli A, Vaziri-Sani F, Lindblad B, Elding-Larsson H, Carlsson A, Forsander G
Diabetes. 2012; 61(10):2556-64.
PMID: 22787139
PMC: 3447907.
DOI: 10.2337/db11-1659.
Is ARE/poly(U)-binding factor 1 (AUF1) a new player in cytokine-mediated beta cell apoptosis?.
Vanzela E, Cardozo A
Diabetologia. 2012; 55(6):1572-6.
PMID: 22526614
DOI: 10.1007/s00125-012-2552-y.
Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.
Gabbay M, Sato M, Duarte A, Dib S
Clin Exp Immunol. 2012; 168(1):60-7.
PMID: 22385239
PMC: 3390495.
DOI: 10.1111/j.1365-2249.2011.04538.x.
An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.
Vermeulen I, Weets I, Costa O, Asanghanwa M, Verhaeghen K, Decochez K
Diabetologia. 2011; 55(2):413-20.
PMID: 22095238
PMC: 3810367.
DOI: 10.1007/s00125-011-2376-1.
Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I, Weets I, Asanghanwa M, Ruige J, Van Gaal L, Mathieu C
Diabetes Care. 2011; 34(8):1760-5.
PMID: 21715527
PMC: 3142046.
DOI: 10.2337/dc10-2268.